Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.

Clinical trial NCT04482257 · UNKNOWN

Trial details

NCT number: NCT04482257
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer

Start date: 2020-07-07
Primary completion: 2020-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.